- Laparoscopic approach to splenectomy
- Frequent incidental finding with increased use of imaging
Latest Updates


- Screening strategies have improved survival, but the effect has plateaued recently. 1
- Oxaliplatin-based adjuvant chemotherapy has extended survival for patients with advanced disease. 2
- The COST trial validated laparoscopic colon resection, while data is emerging regarding the robotic approach. 3,4
- Recent investigations into molecular markers may offer new opportunities for disease detection, prognosis, and treatment. 5-7


Management of Metastatic Castrate-sensitive Prostate Cancer
- Luteinizing hormone–releasing hormone agonists are the current standard of care in androgen deprivation therapy (ADT) for metastatic prostate cancer (mPCa).
- Men with hormone-naive mPCa should be offered six cycles of docetaxel in addition to ADT.
- Abiraterone acetate, in addition to ADT, represents a valid alternative to docetaxel and ADT in men with hormone-naive mPCa.


- Screening strategies have improved survival, but the effect has plateaued recently. 1
- Oxaliplatin-based adjuvant chemotherapy has extended survival for patients with advanced disease. 2
- The COST trial validated laparoscopic colon resection, while data is emerging regarding the robotic approach. 3,4
- Recent investigations into molecular markers may offer new opportunities for disease detection, prognosis, and treatment. 5-7


Failure to Thrive in Infants and Toddlers
- WHO growth charts are recommended for children 0 to 2 years, and CDC growth charts are recommended for children 2 to 18 years of age.
- Blenderized diets may be more wholesome than traditional formula diets for children requiring enteral tube feeding.
- It is important to evaluate whether patients have a true allergy and need to avoid cow’s milk as milk alternatives may contain fewer calories and less protein.


- Discovery of germline RET oncogene mutations leading to MEN2 syndromes and familial medullary thyroid cancer
- Genotype-phenotype correlations for RET mutations allowed targeted screening and intervention in carriers.
- Development of RET-targeted kinase inhibitors (and multikinase inhibitors) as targeted therapies for patients with metastatic and progressive medullary thyroid cancer


- Discovery of germline RET oncogene mutations leading to MEN2 syndromes and familial medullary thyroid cancer
- Genotype-phenotype correlations for RET mutations allowed targeted screening and intervention in carriers.
- Development of RET-targeted kinase inhibitors (and multikinase inhibitors) as targeted therapies for patients with metastatic and progressive medullary thyroid cancer


Stereotactic Body Radiation and Other Ablative Therapies
- Classification of medically inoperable patients with nonsmall cell lung cancer
- Stereotactic body radiotherapy in nonsmall cell lung cancer
- Ablative therapy in nonsmall cell lung cancer
- Bronchoscopic ablation for nonsmall cell lung cancer